• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于局部晚期鼻窦癌的新型分段高剂量姑息性放疗方案:病例报告

A Novel Split-Course High-Dose Palliative Radiotherapy Regimen for Locally Advanced Sinonasal Cancer: A Case Report.

作者信息

Aljabab Saif, Mohaimeed Amna, AlMomen Firas, AlSwailem Abdullah, Alayed Yasir

机构信息

Radiation Oncology Unit College of Medicine King Saud University, Riyadh, Saudi Arabia.

Oncology Center King Saud University Medical City, Riyadh, Saudi Arabia.

出版信息

Case Rep Oncol Med. 2024 Oct 3;2024:9340657. doi: 10.1155/2024/9340657. eCollection 2024.

DOI:10.1155/2024/9340657
PMID:39391741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11466590/
Abstract

Sinonasal malignancies (SNMs) are rare heterogeneous malignancies that frequently present with locally advanced disease. The prognosis is poor when the disease is considered extensive and unresectable. In such cases, a high-dose palliative radiotherapy regimen is often required, but the ideal dose and fractionation have not been established. We detail a 33-year-old male who initially presented with a progressively growing mass over the right cheek. A biopsy of the lesion revealed squamous cell carcinoma (SCC). Imaging revealed a very advanced and unresectable disease with the involvement of several head and neck subsites. He progressed further after receiving induction chemotherapy from an outside institution. The patient requested prompt tumor and symptom control to travel back to his home country. We offered him high-dose split-course palliative radiotherapy in the form of a quad Shot of 14.80 Gy in four fractions twice daily, followed by 30 Gy in five fractions every other day with a 2-week interval. Treatment resulted in excellent clinical response with symptomatic relief in a short time, and the patient could travel back home safely.

摘要

鼻窦恶性肿瘤(SNMs)是罕见的异质性恶性肿瘤,常表现为局部晚期疾病。当疾病被认为广泛且无法切除时,预后很差。在这种情况下,通常需要高剂量姑息性放疗方案,但理想的剂量和分割方式尚未确定。我们详细介绍一名33岁男性,他最初表现为右侧脸颊上逐渐增大的肿块。病变活检显示为鳞状细胞癌(SCC)。影像学检查显示疾病非常晚期且无法切除,累及多个头颈部亚部位。他在接受外院诱导化疗后病情进一步进展。患者要求迅速控制肿瘤和症状以便回国。我们为他提供了高剂量分程姑息性放疗,采用四次照射,每次14.80 Gy,分四次,每天两次,随后每隔一天分五次给予30 Gy,间隔2周。治疗取得了出色的临床反应,短期内症状缓解,患者能够安全回国。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/d9e3163d0d45/CRIONM2024-9340657.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/95062f2283af/CRIONM2024-9340657.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/ca4dcb58e761/CRIONM2024-9340657.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/a4da304acc67/CRIONM2024-9340657.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/d9e3163d0d45/CRIONM2024-9340657.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/95062f2283af/CRIONM2024-9340657.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/ca4dcb58e761/CRIONM2024-9340657.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/a4da304acc67/CRIONM2024-9340657.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d916/11466590/d9e3163d0d45/CRIONM2024-9340657.004.jpg

相似文献

1
A Novel Split-Course High-Dose Palliative Radiotherapy Regimen for Locally Advanced Sinonasal Cancer: A Case Report.一种用于局部晚期鼻窦癌的新型分段高剂量姑息性放疗方案:病例报告
Case Rep Oncol Med. 2024 Oct 3;2024:9340657. doi: 10.1155/2024/9340657. eCollection 2024.
2
Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.局部晚期头颈癌姑息治疗的周期性大分割放疗技术:机构经验及姑息治疗方案综述
J Community Support Oncol. 2016 Jan;14(1):29-36. doi: 10.12788/jcso.0201.
3
Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.对于一名患有多种合并症的85岁腮腺鳞状细胞癌患者,采用调强放疗单独进行的周期性大分割放疗,也称为“四联照射”。
Head Neck. 2017 Apr;39(4):E55-E60. doi: 10.1002/hed.24700. Epub 2017 Feb 7.
4
A Case of Sinonasal Undifferentiated Carcinoma with Brain Metastases.一例伴有脑转移的鼻窦未分化癌
Cureus. 2018 Mar 13;10(3):e2320. doi: 10.7759/cureus.2320.
5
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.四药联合免疫治疗:帕博利珠单抗四联放疗治疗晚期/复发性头颈部癌。
Future Oncol. 2023 Jul;19(22):1523-1534. doi: 10.2217/fon-2022-1146. Epub 2023 May 18.
6
Conventional Fractionation versus Quad Shot in Advanced Head-and-Neck Cancers: A Randomized Controlled Trial.晚期头颈癌的传统分割放疗与四联注射疗法对比:一项随机对照试验
Indian J Palliat Care. 2019 Oct-Dec;25(4):527-534. doi: 10.4103/IJPC.IJPC_209_18.
7
Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.同步整合加量调强放射治疗局部晚期头颈部鳞状细胞癌:II期临床结果
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87. doi: 10.1016/j.ijrobp.2004.03.010.
8
The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.分割疗程低分割姑息性放射治疗在头颈部癌症的应用。
Clin Oncol (R Coll Radiol). 2011 Mar;23(2):141-8. doi: 10.1016/j.clon.2010.09.006. Epub 2010 Oct 8.
9
Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.无法治愈的头颈部癌症的放射治疗肿瘤学组 8502“QUAD shot”方案,使用容积旋转调强弧形治疗。
Oral Oncol. 2024 Apr;151:106752. doi: 10.1016/j.oraloncology.2024.106752. Epub 2024 Mar 21.
10
What Did the Pandemic Teach Us About Palliative Radiation in Head and Neck Cancer?疫情教会了我们哪些关于头颈部癌症姑息性放疗的知识?
J Palliat Care. 2022 Jul;37(3):317-322. doi: 10.1177/08258597211065676. Epub 2021 Dec 6.

本文引用的文献

1
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours.SINTART 2研究。一项针对局部晚期不可切除鼻窦肿瘤患者的诱导化疗、基于光子、质子和碳离子放疗整合的II期非随机对照试验。
Eur J Cancer. 2023 Jul;187:134-143. doi: 10.1016/j.ejca.2023.03.034. Epub 2023 Apr 7.
2
Prognostic Analysis of HPV Status in Sinonasal Squamous Cell Carcinoma.鼻窦鳞状细胞癌中HPV状态的预后分析
Cancers (Basel). 2022 Apr 8;14(8):1874. doi: 10.3390/cancers14081874.
3
What Did the Pandemic Teach Us About Palliative Radiation in Head and Neck Cancer?
疫情教会了我们哪些关于头颈部癌症姑息性放疗的知识?
J Palliat Care. 2022 Jul;37(3):317-322. doi: 10.1177/08258597211065676. Epub 2021 Dec 6.
4
Surgical Management of Sinonasal Cancers: A Comprehensive Review.鼻窦癌的手术治疗:综述
Cancers (Basel). 2021 Aug 8;13(16):3995. doi: 10.3390/cancers13163995.
5
Malignant Sinonasal Tumors: Update on Histological and Clinical Management.恶性鼻-鼻窦肿瘤:组织学和临床管理的最新进展。
Curr Oncol. 2021 Jul 1;28(4):2420-2438. doi: 10.3390/curroncol28040222.
6
Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.采用放疗肿瘤学研究组 8502“QUAD shot”方案的低分割姑息性容积调强弧形放疗治疗不可治愈的头颈部癌症。
Radiat Oncol. 2020 May 27;15(1):123. doi: 10.1186/s13014-020-01548-w.
7
Conventional Fractionation versus Quad Shot in Advanced Head-and-Neck Cancers: A Randomized Controlled Trial.晚期头颈癌的传统分割放疗与四联注射疗法对比:一项随机对照试验
Indian J Palliat Care. 2019 Oct-Dec;25(4):527-534. doi: 10.4103/IJPC.IJPC_209_18.
8
Survival in sinonasal and middle ear malignancies: a population-based study using the SEER 1973-2015 database.鼻窦和中耳恶性肿瘤的生存率:一项基于监测、流行病学和最终结果(SEER)1973 - 2015数据库的人群研究。
BMC Ear Nose Throat Disord. 2018 Aug 9;18:13. doi: 10.1186/s12901-018-0061-4. eCollection 2018.
9
Clinical Presentation and Outcome of Sinonasal Tumors in a Nigerian Tertiary Hospital - 6-year Review.尼日利亚一家三级医院鼻窦肿瘤的临床表现与转归——6年回顾
Niger Med J. 2017 May-Jun;58(3):92-95. doi: 10.4103/nmj.NMJ_265_14.
10
A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.鼻窦恶性肿瘤治疗方式的全面比较分析
Cancer. 2017 Aug 15;123(16):3040-3049. doi: 10.1002/cncr.30686. Epub 2017 Apr 3.